TNFRSF11A / RANK Antibody

LifeSpan BioSciences

TNFRSF11A / RANK Antibody

23

The predicted MW is 28kDa/32kDa/36kDa/56kDa/64kDa/66kDa, while the observed MW by Western blot was 75kDa.

Western Blot, ImmunoHistoChemistry

IHC (1:100 - 1:200), WB (1:1000 - 1:2000) The predicted MW is 28kDa/32kDa/36kDa/56kDa/64kDa/66kDa, while the observed MW by Western blot was 75kDa.

Research Use Only

Polyclonal

Unconjugated

...

TNFRSF11A

TNF receptor superfamily member 11a

CD265, FEO, LOH18CR1, ODFR, OFE, OPTB7, OSTS, PDB2, RANK, TRANCE-R, TRANCER, tumor necrosis factor receptor superfamily member 11A, Paget disease of bone 2, TRANCE receptor, familial expansile osteolysis, loss of heterozygosity, 18, chromosomal region 1, osteoclast differentiation factor receptor, receptor activator of NF-KB, receptor activator of nuclear factor-kappa B, tumor necrosis factor receptor superfamily, member 11a, NFKB activator

Rabbit

IgG

-20°C

12352203